Drugs and the Law in Malaysia

Malaysia has one of the strictest drug regimes in the world. Drugs are called dadah in Malay, and enforcement is heavy, visible, and applied to residents and foreigners alike. Trafficking can still carry a death sentence. Simple use can pull a person into a mandatory treatment and supervision system that lasts years.

This guide explains three things plainly: what the law actually says, what the health risks are, and where to get help in Malaysia. It is written as legal information and harm reduction. It does not tell anyone how to obtain, prepare, conceal, or use any drug, and it does not glamorise use.

A few points shape everything below:

• The main criminal law is the Dangerous Drugs Act 1952 (Act 234), usually shortened to the DDA.
• The law separates consumption, possession, and trafficking, and treats them very differently.
• Weight matters enormously. Once you hold a drug at or above a set weight, the law can presume you are trafficking, which is the offence that can carry death.
• Malaysia also runs a health-led treatment track through the National Anti-Drugs Agency (Agensi Antidadah Kebangsaan, AADK). Voluntary treatment is available and confidential.

If you take one thing from this page: the penalties are real and severe, and help is real and available. Both are true at the same time.

The two core statutes

• Dangerous Drugs Act 1952 (Act 234) is the main criminal-control law for dangerous drugs (opium, cannabis, coca and cocaine, heroin and morphine, amphetamine-type stimulants, and others). It governs possession, cultivation, import and export, consumption, and trafficking.
• Poisons Act 1952 (Act 366) regulates poisons, pharmaceuticals, and psychotropic substances. It controls sale, supply, storage, and dispensing, and is largely a pharmacy and medicines-control regime. Kratom (ketum) is controlled through this Act, not the DDA (see the kratom section).
• Drug Dependants (Treatment and Rehabilitation) Act 1983 (Act 283) is the treatment and rehabilitation regime run by AADK. It was amended in 2024 and the amended Act came into force on 22 August 2025.

How substances are classified

The DDA First Schedule lists controlled dangerous drugs, split into Parts I through V (and Part VA). Different offence sections apply to different Parts. The Minister can amend Parts III, IV, and V of the First Schedule by gazette order to add or remove drugs, and Section 45A lets the Minister bring substances under control when the UN drug-control commission changes its own schedules. New substances are added by gazette.

The three legal tiers, least to most serious

1. Consumption / self-administration, Section 15. Consuming or self-administering a dangerous drug, or being found on premises used for drug consumption, carries a fine not exceeding RM5,000 or imprisonment not exceeding 2 years (no whipping). Section 15(2) defines "consumes" broadly (eat, chew, smoke, swallow, drink, inhale, or introduce into the body by any means). Repeat or aggravated consumption can escalate under s.39C to longer prison terms plus whipping. This is the least serious tier and is often diverted into the treatment track.

2. Possession. Section 6 covers possession of raw opium, coca leaves, poppy-straw, or cannabis (or their seed plants) without authorisation: a fine not exceeding RM20,000, or imprisonment not exceeding 5 years, or both. Section 12(2) covers possession of other dangerous drugs the Part applies to: under s.12(3), a fine not exceeding RM100,000, or imprisonment not exceeding 5 years, or both. Section 6B (planting or cultivating opium, coca, poppy, or cannabis) is far heavier: imprisonment for life and whipping of not less than 6 strokes. Section 39A adds an intermediate weight band (below the trafficking presumption) with imprisonment plus caning that rises with quantity.

3. Trafficking, Section 39B. Section 39B(1) prohibits trafficking, offering to traffic, or any act preparatory to trafficking. "Trafficking" is defined widely in s.2: it includes manufacturing, selling, giving, distributing, transporting, sending, delivering, or keeping and storing for those purposes. A person can be convicted of trafficking without ever making a sale. Prosecution requires the Public Prosecutor's consent (s.39B(3)).

Section 37: the presumptions that shift the burden

Section 37 sets out rebuttable presumptions that apply "until the contrary is proved," shifting the evidential burden onto the accused. Two matter most:

• s.37(d): anyone with custody or control of anything containing a dangerous drug is presumed to possess it and to know its nature.
• s.37(da): the trafficking presumption by weight. Possession at or above these amounts means the person is presumed to be trafficking (rebuttable). These are legal presumption lines, not safe quantities. Small amounts are still crimes under s.6, s.12, and s.15.

Once weight is proved, the burden flips to the accused to show the drug was, for example, for personal use or not knowingly possessed. Human-rights groups have long criticised this burden-shifting.

The 2023 reform: mandatory death penalty abolished

The Abolition of Mandatory Death Penalty Act 2023 (Act 846) was passed by the Dewan Rakyat on 3 April 2023 and the Dewan Negara on 11 April 2023, and came into force on 4 July 2023. It removed the mandatory death penalty across Malaysian law (11 offences previously carried a mandatory death sentence) and amended 7 statutes including the DDA.

For s.39B trafficking, the effect is that death is no longer mandatory. Judges may now impose an alternative sentence (imprisonment plus whipping of not less than 12 strokes) instead of death. Death remains a lawful, available sentence. Malaysia did not abolish capital punishment itself, and the Health Ministry confirmed in 2024 that there are no plans to remove the death penalty from the DDA. A companion law let existing death-row prisoners apply to the Federal Court for resentencing, and many drug-trafficking death sentences have since been commuted to imprisonment plus whipping.

One caution on the exact alternative term: sources differ on whether the s.39B alternative to death is imprisonment for life or a fixed term (some report 30 to 40 years). Confirm the current consolidated s.39B wording against the gazetted Act before relying on a specific number of years.

For fuller treatment of how capital punishment works in Malaysia, see a dedicated death-penalty guide (malaysia4u.com). The reform changed sentencing discretion. It did not touch the s.37 presumptions or the weight thresholds.

All of the substances below are controlled under the Dangerous Drugs Act 1952. The descriptions here are legal and health-focused. Nothing below is a guide to use.

Methamphetamine (*syabu*), the dominant drug

Methamphetamine, called syabu on the street, is the most prevalent illicit drug in Malaysia by official data. Amphetamine-type stimulants (ATS), chiefly meth, account for the large majority of treatment admissions (commonly cited above 70%), and meth overtook opioids as the leading drug around 2017 to 2020. Its s.37(da) trafficking presumption is 50 g. Health risks include severe stimulant dependence, psychosis and paranoia, cardiovascular strain, weight loss, dental and skin damage, and high relapse rates.

Cannabis (*ganja*)

Fully illegal under the DDA, with no recreational exemption. Possession under 20 g attracts up to 5 years and a fine up to RM20,000; 20 g to 50 g attracts imprisonment plus whipping under s.39A; the s.37(da) trafficking presumption is 200 g. THC and CBD are treated as dangerous drugs. Health risks include dependence, respiratory harm from smoking, impaired attention and memory, and psychiatric risk in vulnerable individuals. Increasingly seen in vape and edible form, which raises adulteration risk.

Heroin and other opioids

Heroin, morphine, and monoacetylmorphine carry the lowest major trafficking threshold at 15 g, reflecting Malaysia's historic opioid focus. Heroin was the traditional drug of dependence and now sits second to meth, but it still drives injecting-drug use and associated HIV and hepatitis C transmission. Malaysia runs methadone maintenance therapy and needle and syringe programmes as public-health harm reduction. Health risks include high overdose and fatality risk from respiratory depression, physical dependence, and infection from injecting.

MDMA (ecstasy) and other ATS "party" drugs

MDMA is a dangerous drug with a s.37(da) presumption at 50 g and an intermediate s.39A band cited as 5 g up to 30 g. Pills are frequently adulterated with other substances, which adds unpredictability. Health risks include hyperthermia, dehydration or overhydration, cardiac risk, and mood effects on comedown.

Ketamine

Controlled under the DDA and prominent in recent seizure and border-screening data. Its specific trafficking threshold is not clearly confirmed in public sources as of 2026, so it is not stated here. Health risks include dissociation, bladder and urinary-tract damage with heavy use ("ketamine bladder"), and dependence.

Cocaine and opium

Cocaine carries a s.37(da) presumption at 40 g (coca leaves at 2,000 g). Raw and prepared opium carry a presumption at 1,000 g. Both are far less common in Malaysia than meth, cannabis, and heroin.

Addiction to any of these is a treatable medical condition. Dependence is not a moral failing, and voluntary help exists (see the help section).

Kratom, known in Malaysia as ketum (the plant Mitragyna speciosa), is controlled through its active alkaloid mitragynine, which is listed under the Poisons Act 1952 (Act 366), not the Dangerous Drugs Act. Multiple academic and legal sources place the listing at 2003, in the First Schedule (Poisons List) and the Third Schedule (Psychotropic substances).

Bottom line as of 2026: ketum is regulated as a Poisons Act matter through mitragynine. It is an offence to import, export, manufacture, sell, or possess preparations containing mitragynine without authorisation. Because mitragynine is a listed psychotropic substance, offences fall under s.30(3) of the Poisons Act 1952 and are penalised under s.30(5): a fine up to RM100,000, or imprisonment up to 5 years, or both. These figures were raised by the Poisons (Amendment) Act 2022 (Act A1666). The older figure of up to RM10,000 or up to 4 years is out of date and predates that amendment, though some articles still quote it.

It is not scheduled under the DDA. Despite repeated calls to move ketum under the DDA (the Malaysian Substance Abuse Council urged the government to "gazette ketum as a dangerous drug immediately," reported around 2023), that reclassification has not been gazetted. Any online claim that ketum "became a dangerous drug under the DDA in 2021" is uncorroborated and should be treated as wrong. Reporting through 2024 and 2025 continued to describe ketum as controlled only under the Poisons Act.

A real 2024 change did affect ketum users. The Drug Dependants (Treatment and Rehabilitation) (Amendment) Bill 2024, passed by the Dewan Rakyat on 18 July 2024, broadened the treatment and rehabilitation regime to sweep in psychotropic substances under the Poisons Act (which includes mitragynine) and toluene. This means ketum users can now be brought into the treatment and rehabilitation system, even without DDA scheduling.

A live policy fight. One camp (the Malaysian Substance Abuse Council, some MPs) wants ketum moved to the DDA and cultivation explicitly banned, arguing a legal gap lets the standing tree be grown while only the leaf preparation is clearly controlled. Another camp, including northern-state politicians in Kedah and Perlis, wants ketum-leaf cultivation legalised and regulated as an export cash crop, pointing to Thailand's decriminalisation (2021 to 2022) and a much higher price across the border (northern politicians cited roughly RM150 per kg in Thailand against about RM30 per kg locally). Researcher Dr Darshan Singh (Universiti Sains Malaysia) argues the Poisons Act is already sufficient and that a rush to ban is unwarranted, noting the WHO Expert Committee on Drug Dependence found no strong evidence to justify international scheduling.

Traditional use (air ketum). Leaves are brewed into air ketum (kratom water), a long-standing folk practice in the northern and rural peninsula (Kedah, Perlis, Kelantan, Terengganu), used as a remedy for fever, pain, and diarrhoea, and as a stamina tonic by rubber tappers and farmers. Field research from Universiti Sains Malaysia's Centre for Drug Research documents regular use concentrated among older rubber tappers and farmers, who take it for joint pain and stamina while staying employed.

Health framing. Mitragynine acts on opioid receptors and can produce both stimulant and sedative, opioid-like effects. Regular heavy use is associated with dependence and withdrawal, and Malaysian concern focuses on adulterated or high-concentration cocktails rather than traditional dilute air ketum. Help is available for ketum dependence through AADK without shame or automatic criminal exposure.

Current status as of 2026: cannabis and CBD are illegal for general sale and possession in Malaysia. There is no separate legal CBD category and no permitted THC limit for consumer products. Cannabis-derived products fall under the Dangerous Drugs Act 1952.

The only legal route historically has been use for medical, research, or educational purposes with authorisation by the Minister of Health under the DDA, carried out by an authorised public officer. That authorisation has rarely been granted.

The debate. In 2022, then Health Minister Khairy Jamaluddin said the government welcomed clinical trials and was developing a framework, citing Thailand as a model. A MARDI feasibility study reported majority public and professional support for medical cannabis.

The March 2025 development. The Health Ministry announced that registration of cannabis-based products is open: applicants with sufficient scientific evidence may register through the standard NPRA and Drug Control Authority pathway, the same route as other pharmaceuticals, subject to existing law. This opened a regulatory door for registered medicinal products. It did not legalise recreational cannabis or CBD, and possession or sale of unregistered or illegal cannabis products remains an offence.

Personal imports are risky. The Control of Drugs and Cosmetics Regulations 1984 exempt a traveller importing a personal-use medicine (up to about one month's supply) from registration requirements, but this general medicines provision does not override the DDA prohibition on cannabis. Travellers have faced DDA charges for cannabis or CBD products. Do not read the personal-import exemption as permitting cannabis or CBD.

Taxation did not legalise cannabis. After a 2025 report of a 5% SST line touching cannabis, the Ministry of Finance clarified that cannabis remains illegal. A tax code did not change the legal status.

This section reports the trafficking picture at a news and statistics level, drawing on UNODC, police, and customs reporting. It contains no operational, routing, or concealment detail.

Methamphetamine (*syabu*) dominates

Syabu is the dominant trafficked and abused drug in Malaysia. Amphetamine-type stimulants account for roughly 70% of drug-abuse cases (national ATS share about 72%), and AADK reporting in 2026 put synthetic drugs at about 83% of all cases, with youths (roughly 15 to 39) the large majority. AADK recorded 192,857 drug-abuse cases in 2024, up from 145,526 in 2023.

Source: the Golden Triangle

The drug is overwhelmingly produced in Myanmar's Shan State, inside the Golden Triangle (the Myanmar, Laos, and Thailand tri-border). UNODC attributes a sharp rise in production to instability since the 2021 coup. UNODC's 2025 report (covering 2024) recorded a regional record of about 236 tonnes of methamphetamine seized across East and Southeast Asia, up about 24% on 2023, with Southeast Asia accounting for roughly 85% of the total.

Malaysia as a transit and consumption hub

UNODC and Malaysian police describe Malaysia as both a consumption market and a transit country. Drugs from the Golden Triangle move through Malaysia toward onward destinations, notably Australia, and Sabah is named as a key regional transit point. Malaysia also handles shipments sourced from outside the region.

Falling prices, record seizures

UNODC's central finding is that meth prices fell sharply across Southeast Asia over roughly 2020 to 2024 while purity stayed stable or rose, the signature of a production surge rather than a supply squeeze. A Myanmar meth tablet fell from about US$2.50 in 2020 to around US$0.60 in 2024; wholesale crystal meth roughly halved. A precise Malaysia-specific syabu price curve is not separately confirmed here.

Malaysia's largest-ever drug bust came at Port Klang (West Port) on 25 January 2025: about 33.2 tonnes of methamphetamine, valued at around RM1.062 billion, found in 166 drums across two containers bound for Australia. An important caveat: the Australian Federal Police described the material as methamphetamine-laced paraffin wax, so the headline tonnage is gross seized weight, not pure crystal meth, and the origin was reported as Iran or Central Asia rather than the Golden Triangle. In a separate case, Op Chrysogaster (2 March 2026) seized more than 3.4 tonnes of methamphetamine (about 3,402 kg, valued at around RM170 million) in a raid at Old Klang Road, Kuala Lumpur, believed brought in from a Golden Triangle network.

Synthetic drugs and new psychoactive substances

Drug-laced vapes are the fastest-rising new-psychoactive-substance threat in Malaysia. Substances detected in vape liquids include ketamine, methamphetamine, and etomidate (a pharmaceutical anaesthetic increasingly diverted and analogued, flagged by UNODC in 2025). One Kelantan sample cited about 76% of seized vapes containing controlled substances, though that figure is local, not a confirmed national rate. UNODC's early-warning system reported 101 newly emerged NPS in 2024 across the region.

How foreigners and young Malaysians get exploited as mules

Police reporting repeatedly describes couriers ("mules") recruited through fake job offers, including TikTok and social-media job scams, then used to carry drugs through airports. KLIA operations in 2025 and 2026 dismantled syndicates using first-time couriers lured with promised rewards (reported at least RM5,000 per trip plus sponsored tickets and accommodation), including groups of young foreigners aged 18 to 27 paid in pounds or euros. Malaysians are victimised abroad too: a 19-year-old from Sarawak was detained at Hong Kong airport in July 2026 carrying about 3 kg of cannabis, believed recruited as a mule. The pattern is consistent: financially vulnerable, often first-time people recruited under deception, then exposed to trafficking penalties that can include death. Carrying a bag for someone is not a defence against the s.37 trafficking presumption.

Malaysia runs a dual system. A positive urine test or an admission of use does not automatically mean a criminal conviction. AADK and the prosecutor decide the track: treatment and supervision, or prosecution.

On arrest

• Urine or bodily-specimen test (s.31A DDA). On arrest for a DDA offence, police may require a urine specimen. An officer of Sergeant rank or above, or a Customs officer, may take it if a medical officer cannot. A positive test can found a s.15 consumption charge or a s.3 assessment under Act 283. Malaysia treats a positive test as evidence of consumption in Malaysia.
• Suspected-dependant detention (s.3(1) Act 283). A person suspected of dependence can be detained for a screening test and, while awaiting the confirmatory laboratory result, may be held for assessment (a period of up to 14 days is widely cited).
• Ordinary remand (s.117 CPC). For a prosecutable offence, police apply to a Magistrate for remand, commonly up to 14 days for serious offences. A Magistrate must authorise any remand beyond the first 24 hours.
• Bail. Availability depends on the charge. Trafficking under s.39B is non-bailable and is tried in the High Court.

Two tracks

Rehabilitation and supervision (health track, Act 283). After a medical officer certifies dependence, a Magistrate may order, on an AADK officer's recommendation, detention at a Cure & Care Rehabilitation Centre for 2 years followed by about 2 years of community supervision (s.6(1)(a)), or community supervision alone for 2 to 3 years with counselling and random urine tests (s.6(1)(b)). A person may also present voluntarily at a Cure & Care clinic for treatment without being prosecuted (s.8(3)(a)). At Malaysia's first Drug Policy Summit in November 2025, Prof Adeeba Kamarulzaman (a Commissioner of the Global Commission on Drug Policy) cited 2023 arrest data indicating about 85% of drug arrests are of people suspected of using drugs or caught with amounts too small to meet the minor-possession threshold, against about 15% for trafficking. The policy direction has been to divert users toward treatment.

Prosecution (criminal track, DDA). Chosen for possession above user levels, dealing, and trafficking. It produces a criminal conviction, a record, and the penalties below.

Penalties at a glance

Caning (whipping, rotan) is a standard additional penalty for many DDA offences. By general law (Criminal Procedure Code s.289), women and men over 50 are exempt from whipping for many offences, so the caning element may not apply to every convict. Verify applicability in a specific case.

After the case

A DDA conviction creates a criminal record held by the police, which can surface in background and licensing checks. A rehabilitation or supervision order under Act 283 is an AADK administrative record rather than a criminal conviction, but supervision conditions restrict movement and require reporting, and breach is a fresh offence. A conviction or an active order can bar overseas travel and complicate visa applications elsewhere.

Foreigners are subject to the identical Dangerous Drugs Act penalties, including the death penalty for trafficking. There is no tourist exemption and no "personal amount" safe harbour comparable to some Western jurisdictions.

• Border interdiction. Customs and police screen arriving and departing passengers. Being an unwitting courier is not a defence against the s.37 trafficking presumption. Several foreign nationals have received death sentences for trafficking detected at Malaysian airports.
• Weight decides the charge. A quantity that a traveller thinks of as small can cross a s.37(da) threshold and become a trafficking charge. The three most-cited lines are heroin or morphine at 15 g, methamphetamine at 50 g, and cannabis at 200 g.
• Consular help is limited. An embassy can visit, provide a lawyer list, and monitor treatment. It cannot obtain release, override Malaysian courts, or prevent a lawful sentence. Government travel advisories (for example the US State Department and UK FCDO) warn explicitly that Malaysia imposes severe penalties, including death, for drug offences.
• Immigration blacklist and deportation. A drug conviction leads to being blacklisted by the Immigration Department, barring future entry. After serving a sentence, a foreigner is typically deported and blacklisted, and even non-custodial outcomes can lead to blacklisting. Removing a blacklist is slow and not guaranteed.
• If arrested, you have the right to contact a lawyer and, as a foreigner, your embassy or consulate. Engage a lawyer experienced in DDA cases immediately, especially before making any statement and in any s.39A or s.39B matter.

Addiction is treated here as a health condition. Voluntary treatment exists, it is confidential, and seeking help is encouraged. You can approach the system yourself without being arrested.

AADK (*Agensi Antidadah Kebangsaan*, the National Anti-Drugs Agency)

AADK is the lead federal agency for prevention, treatment, and rehabilitation, under the Ministry of Home Affairs. It runs the national treatment network, community supervision, and prevention programmes.

• AADK 24-hour hotline: 1-800-22-2235 (1-800-22-AADK), operated from the Hotline Operations Center at AADK HQ.
• AADK WhatsApp: 019-626 2233
• AADK main line: 03-8911 2200 (HQ in Kajang, Selangor)
• Website: aadk.gov.my (Cure & Care directory and list of licensed private rehab centres)

The Cure & Care network (where treatment happens)

AADK's Cure & Care family began replacing compulsory detention from around 2010, when AADK started converting 10 of its 28 compulsory centres into voluntary Cure & Care centres. The main service types are:

• Klinik Cure & Care 1Malaysia: open-access, voluntary outpatient clinics offering medication-assisted treatment including methadone maintenance therapy, counselling, and psychosocial support.
• Cure & Care Rehabilitation Centre (CCRC): residential treatment (voluntary and court-ordered), formerly branded PUSPEN.
• Cure & Care Service Centre (CCSC): community drop-in and outpatient aftercare.
• Cure & Care Vocational Centre (CCVC) and Caring Community House (CCH): vocational training, reintegration, and halfway aftercare.

Cure & Care services are reported as voluntary, community-based, and free of charge.

Health-led harm reduction

Malaysia adopted harm reduction in 2005, introduced methadone maintenance therapy in October 2005, and formally launched a Needle and Syringe Exchange Programme (NSEP) in February 2006 with the Malaysian AIDS Council and the Ministry of Health. Methadone and buprenorphine are used for opioid dependence and to reduce HIV and hepatitis C transmission. Malaysia is cited as a regional best-practice model for reversing HIV among people who inject drugs, and later exceeded the global 50% opioid agonist treatment coverage target, reaching about 70% based on 2017 to 2021 data.

Other help

• Ministry of Health clinics and hospitals run methadone and harm-reduction services; any government klinik kesihatan can provide medical help and referral.
• Talian Kasih 15999: national social-welfare and crisis helpline that can route to services.
• PENGASIH Malaysia (founded 1991, pengasih.asia): community-based recovery and support using a therapeutic-community model.
• Malaysian AIDS Council (mac.org.my): harm reduction, NSEP coordination, HIV and HCV testing, and referral.
• Befrienders (state centres) for emotional support if drug use is entangled with distress.
• Medical emergency or suspected overdose: call 999 or go to the nearest government hospital emergency department (Jabatan Kecemasan).

AADK reported 689 voluntary self-referrals for treatment by 31 May 2025, and the government allocated around RM480 million to AADK operations and rehabilitation centres in 2025. Seeking help voluntarily is a recognised, supported pathway.

Malaysia has moved toward a health-framed, rehab-first model while keeping strict prohibition and capital trafficking penalties. It has not decriminalised personal drug use.

The 2019 proposal

On 27 June 2019, Health Minister Dzulkefly Ahmad announced an intent to decriminalise possession and use of small quantities for personal use, remove criminal penalties, and divert people to treatment, calling it a move toward a "rational drug policy that puts science and public health before punishment." It was explicitly framed as not legalisation and not for trafficking. Thresholds and timing were never finalised, and the proposal stalled after the government changed in February 2020.

The 2023 revival and what actually passed

Home Minister Saifuddin Nasution Ismail said in 2023 that a bill to decriminalise small-scale possession and use was "in the works." What actually passed was the treatment law, not DDA decriminalisation. The Drug Dependants (Treatment and Rehabilitation) (Amendment) Bill 2024 passed the Dewan Rakyat on 18 July 2024 and the Dewan Negara on 1 August 2024, renamed the parent Act to cover substance dependants and misusers, and came into force around 22 August 2025. It treats dependence as a recurring disease, expands scope to all substance misuse including ketum and inhalants, creates a voluntary treatment pathway, and empowers rehab officers to recommend treatment rather than automatic imprisonment or caning.

Why this is not decriminalisation

NGOs and reform advocates (including HAYAT, the Drug Policy Program Malaysia, and commentary carried by CodeBlue) stress that this is not decriminalisation. Possession and use remain criminal offences under the Dangerous Drugs Act 1952, which was not amended in tandem, and the treatment regime retains compulsory and coercive elements. Real decriminalisation, they argue, would require amending the DDA itself. Treat any "Malaysia has decriminalised drug use" claim as inaccurate.

Regional context

Malaysia sits between the region's punitive and reformist poles. It keeps strict prohibition and capital trafficking penalties (like Singapore and Indonesia), yet was an early adopter of harm reduction (NSEP and MMT since around 2005 to 2006), which is unusual for Southeast Asia. Thailand legalised medical cannabis (2018) and briefly decriminalised recreational use before re-tightening. The Philippines has been the most punitive since 2016. Malaysia's headline stance as of 2026 remains prohibitionist with a growing treatment and harm-reduction layer.

Why the health argument keeps returning

Relapse is cited consistently at around 50%, minor-drug offenders have historically made up over half the prison population, and the 2024 case count rose 32.5% year on year. Those numbers are the empirical backbone of the case for a health-led approach.

Where things stand as of 2026:

• The law is strict and largely unchanged in its core. The Dangerous Drugs Act 1952 still governs possession, consumption, and trafficking. The three-tier structure (s.15 consumption, s.6 and s.12 possession, s.39B trafficking) and the s.37 weight presumptions remain in force.
• The death penalty for trafficking is discretionary, not gone. Since 4 July 2023, judges may choose imprisonment plus caning over death, and many death sentences have been commuted, but death remains a lawful sentence and the government has stated no plans to remove it.
• Meth (syabu) dominates. Synthetic drugs make up about 83% of cases in 2026 AADK reporting, supplied largely from the Golden Triangle, with falling prices and record regional seizures. Drug-laced vapes, including etomidate and ketamine, are the fastest-rising new threat.
• Kratom (ketum) is still a Poisons Act matter, not a DDA drug, though users can now be drawn into the treatment system and the reclassification debate is unresolved.
• Cannabis and CBD remain illegal for general use, with a narrow, tightly controlled door opened in March 2025 for registered medicinal products.
• The treatment system has expanded and softened at the edges. Act 283 (amended, in force from 22 August 2025) frames dependence as a recurring disease and widens voluntary treatment. This is a policy shift toward health. It does not decriminalise use.

If you are a resident or a traveller: the safest reading of Malaysian law is that any drug offence carries real, severe consequences, and that weight can turn possession into a capital charge. If you or someone you know is struggling with drugs, help is genuinely available, confidential, and free through AADK and the Cure & Care network. Both statements are current as of 2026.